Evidence map›Paper›PMID 30819783›Full record

ArticlePlant physiology2019

CyanoGate: A Modular Cloning Suite for Engineering Cyanobacteria Based on the Plant MoClo Syntax.

Ravendran Vasudevan, Grant A R Gale, Alejandra A Schiavon, Anton Puzorjov, John Malin, Michael D Gillespie, Konstantinos Vavitsas, Valentin Zulkower, Baojun Wang, Christopher J Howe and 2 more

Abstract read
In one paragraph

Article in Plant physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed.

  1. Review
  2. Article
  3. EngineeringMetabolic engineering communications · 2026
    Article
  4. Conversion of COMicrobial cell factories · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. EngineeringbioRxiv : the preprint server for biology · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Co-expression of auxiliary genes enhances the activity of a heterologous OBiotechnology for biofuels and bioproducts · 2025
    Article
  19. Review
  20. Genetic engineering in diatoms: advances and prospects.The Plant journal : for cell and molecular biology · 2025
    Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Ravendran VasudevanInstitute of Molecular Plant Sciences, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3BF, United Kingdom.ORCID 0000-0001-9195-1116
Grant A R GaleInstitute of Molecular Plant Sciences, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3BF, United Kingdom.
Alejandra A SchiavonInstitute of Molecular Plant Sciences, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3BF, United Kingdom.
Anton PuzorjovInstitute of Molecular Plant Sciences, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3BF, United Kingdom.
John MalinInstitute of Molecular Plant Sciences, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3BF, United Kingdom.ORCID 0000-0002-1991-8693
Michael D GillespieSchool of Biological Sciences, University of East Anglia, Norwich NR4 7TJ, United Kingdom.
Konstantinos VavitsasAustralian Institute of Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland 4072, Australia.ORCID 0000-0002-6828-1000
Valentin ZulkowerCentre for Synthetic and Systems Biology, University of Edinburgh, Edinburgh EH9 3BF, United Kingdom.
Baojun WangCentre for Synthetic and Systems Biology, University of Edinburgh, Edinburgh EH9 3BF, United Kingdom.ORCID 0000-0002-4858-8937
Christopher J HoweDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1QW, United Kingdom.ORCID 0000-0002-6975-8640
David J Lea-SmithSchool of Biological Sciences, University of East Anglia, Norwich NR4 7TJ, United Kingdom.ORCID 0000-0003-2463-406X
Alistair J McCormickInstitute of Molecular Plant Sciences, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3BF, United Kingdom alistair.mccormick@ed.ac.uk.ORCID 0000-0002-7255-872X

Funding

Biotechnology and Biological Sciences Research Council BB/M010996/1Biotechnology and Biological Sciences Research Council BB/M025659/1Biotechnology and Biological Sciences Research Council BB/N007212/1
6 · The paper itself

Abstract

Recent advances in synthetic biology research have been underpinned by an exponential increase in available genomic information and a proliferation of advanced DNA assembly tools. The adoption of plasmid vector assembly standards and parts libraries has greatly enhanced the reproducibility of research and the exchange of parts between different labs and biological systems. However, a standardized modular cloning (MoClo) system is not yet available for cyanobacteria, which lag behind other prokaryotes in synthetic biology despite their huge potential regarding biotechnological applications. By building on the assembly library and syntax of the Plant Golden Gate MoClo kit, we have developed a versatile system called CyanoGate that unites cyanobacteria with plant and algal systems. Here, we describe the generation of a suite of parts and acceptor vectors for making (1) marked/unmarked knock-outs or integrations using an integrative acceptor vector, and (2) transient multigene expression and repression systems using known and previously undescribed replicative vectors. We tested and compared the CyanoGate system in the established model cyanobacterium

Indexed as

Cloning, MolecularClustered Regularly Interspaced Short Palindromic RepeatsCyanobacteriaGene Knock-In TechniquesGene Knockout TechniquesGenetic EngineeringGenetic VectorsPromoter Regions, GeneticSynechocystisSynthetic Biology

Identifiers

PMID30819783
PMCPMC6501082

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.